What Region Is Most Associated with Fracture-Associated Prescription Drug Use?
Many commonly prescribed drugs—such as some sleep aids—are known to carry an increased risk of breaking a bone, by increasing falls, weakening bones, or both.
Many commonly prescribed drugs—such as some sleep aids—are known to carry an increased risk of breaking a bone, by increasing falls, weakening bones, or both.
Health Union, which creates condition-specific online patient communities, shared results from its Sleep Disorders In America survey.
Narcolepsy, a relatively rare and poorly understood neurological condition, can be hard to diagnose. Julea Steiner was misdiagnosed for years before a sleep study helped doctors recognize her symptoms—excessive daytime sleepiness, vivid dreams, hallucinations, and mild cataplexy—as narcolepsy.
A registry study involving 2 million pregnant women shows no association between modafinil and an increased risk of malformation in babies.
Read MoreHighlights include presentations on Xywav, a lower sodium oxybate iindicated for the treatment of cataplexy or excessive daytime sleepiness (EDS) in patients 7 years of age and older with narcolepsy.
Read MoreThe data include a final analysis of the Pitolisant Expanded Access Clinical Evaluation Program, two post-hoc analyses on clinically relevant outcomes from the Phase 3 clinical trials, and analyses that further characterize the cardiac safety profile of WAKIX.
Read MoreHighlights include an oral presentation focusing on the long-term efficacy and safety of DAYVIGO in adults ages 65 and older with insomnia disorder from the Phase 3 clinical study.
Read MoreNew findings confirm the persistence of a drug dose gender gap stemming from a historic disregard of the biological differences between male and female bodies.
Read MorePatients are vulnerable in the period after discharge, when risks and adverse reactions can result in ER visits, rehospitalization, and even death within 30 days.
Read MoreDAYVIGO targets orexin receptors to facilitate sleep. It’s been trialed in the elderly and in patients with common comorbidities.
Read MoreMarketed by Jazz Pharmaceuticals, Xywav is for the treatment of cataplexy or excessive daytime sleepiness in patients 7 years of age and older with narcolepsy.
Read MoreThis decline was partially compensated for by a rise in the use of a nonbenzodiazepine drug called zopiclone.
Read MoreBenzodiazepines and prescription sleep aids should not be the first resort and they are not meant for long-term, emphasizes Lifehacker Australia.
Read More“These data on the efficacy and safety of WAKIX strengthen the body of scientific evidence that supports WAKIX as a potential treatment option for adult patients living with narcolepsy.”
Read MoreResearch from Express Scripts reveals the coronavirus is making a significant impact on mental health.
Read MoreSleep Medicine has published an article that reviews the mechanism of action of available treatments for patients with narcolepsy.
Read MoreSolriamfetol, a dopamine and norepinephrine reuptake inhibitor, offers short-term improvements in health-related quality of life (HRQoL), and work productivity in people with narcolepsy, according to study results published in Sleep Medicine.
Read MoreThe antidepressant trazodone is commonly prescribed to treat insomnia. An article by Consumer Reports looks into the safety of this practice. A handful of studies have shown that trazodone may improve sleep during the first...
Read More